To compare intralesional and oral propranolol for treating periorbital and eyelid capillary hemangiomas.


Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
12 2019
Historique:
entrez: 23 11 2019
pubmed: 23 11 2019
medline: 11 7 2020
Statut: ppublish

Résumé

A pilot randomized control trial to compare the efficacy and side effects of intralesional and oral propranolol in periorbital and eyelid capillary hemangiomas. Twenty patients were prospectively randomized to two groups of ten each. Group 1 was initiated on oral propranolol 1 mg/kg/day titrated to final dose of 3 mg/kg/day over 1 week which was continued for 6 months and then tapered over 1 week; Group 2 received 3 doses of direct intralesional propranolol hydrochloride 1 mg/ml; 0.2 ml/cm 4-6 weeks apart. Hemangioma area and corneal astigmatism were measured. Within each group at 6 months there was a significant reduction in area (group 1: 83.48 ± 11.67%,P= 0.0019; group 2: 67.78 ± 21.71%,P= 0.0019) and improvement in astigmatism (pre, post: group 1: 2.98D @ 179.8°, 1.13D @ 179.8°,P= 0.0045; group 2: 1.62D @ 90.16°, 0.75D @ 179.9°,P= 0.0001). There was no difference in area reduction (P = 0.056), change in appearance (P = 0.085), ptosis (P = 0.23) and side effects (lethargy, poor feeding;P= 0.171) between the two groups. Efficacy and side effects with intralesional propranolol are comparable to oral propranolol for periorbital and eyelid lesions.

Identifiants

pubmed: 31755431
pii: IndianJOphthalmol_2019_67_12_1974_271389
doi: 10.4103/ijo.IJO_59_19
pmc: PMC6896529
doi:

Substances chimiques

Adrenergic beta-Antagonists 0
Propranolol 9Y8NXQ24VQ

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1974-1980

Commentaires et corrections

Type : CommentIn

Déclaration de conflit d'intérêts

None

Références

Clin Exp Ophthalmol. 2010 Aug;38(6):554-9
pubmed: 20491798
Eye (Lond). 2011 Dec;25(12):1627-34
pubmed: 21921959
Clin Exp Ophthalmol. 2010 Aug;38(6):547-53
pubmed: 20553300
J Ocul Pharmacol Ther. 2011 Oct;27(5):453-9
pubmed: 21810027
Eur J Dermatol. 2013 Sep-Oct;23(5):646-52
pubmed: 24135427
Pediatr Dermatol. 2013 Mar-Apr;30(2):182-91
pubmed: 23405852
Br J Dermatol. 2010 Aug;163(2):269-74
pubmed: 20456345
Middle East Afr J Ophthalmol. 2010 Apr;17(2):121-8
pubmed: 20616917
J Cataract Refract Surg. 2001 Jan;27(1):61-79
pubmed: 11165858
Pediatrics. 2009 Sep;124(3):e423-31
pubmed: 19706583
J Am Acad Dermatol. 2011 Aug;65(2):320-327
pubmed: 21601311
Pediatr Dermatol. 1989 Mar;6(1):39-42
pubmed: 2704661
Eye (Lond). 2011 Oct;25(10):1277-83
pubmed: 21738233
In Vitro Cell Dev Biol Anim. 2002 May;38(5):298-304
pubmed: 12418927
Br J Dermatol. 2014 Apr;170(4):907-13
pubmed: 24641194
J AAPOS. 2010 Jun;14(3):251-6
pubmed: 20603059
J Pediatr. 2007 Mar;150(3):291-4
pubmed: 17307549
Ophthalmology. 1979 May;86(5):760-92
pubmed: 545208
Middle East Afr J Ophthalmol. 2011 Oct;18(4):298-303
pubmed: 22224018
Plast Reconstr Surg. 1982 Mar;69(3):412-22
pubmed: 7063565
N Engl J Med. 2015 Feb 19;372(8):735-46
pubmed: 25693013
J AAPOS. 2016 Feb;20(1):30-3
pubmed: 26917068
Pediatr Dermatol. 2014 Mar-Apr;31(2):156-8
pubmed: 24000875
J AAPOS. 2009 Dec;13(6):567-70
pubmed: 20006818
Arch Ophthalmol. 2011 Jul;129(7):899-903
pubmed: 21402978
Br J Ophthalmol. 2011 Sep;95(9):1199-202
pubmed: 21131380
J Pediatr Surg. 2012 Dec;47(12):2216-23
pubmed: 23217879
Am J Ophthalmol. 1978 Jun;85(6):806-13
pubmed: 677206
J Cataract Refract Surg. 1993 May;19(3):393-8
pubmed: 8501636
Ophthalmic Surg. 1986 Apr;17(4):229-31
pubmed: 3714192
J Pediatr Ophthalmol Strabismus. 1980 Jan-Feb;17(1):29-36
pubmed: 7365646
N Engl J Med. 2008 Jun 12;358(24):2649-51
pubmed: 18550886
Clin Ophthalmol. 2011;5:1135-40
pubmed: 21887095
Ann Surg. 2012 Jul;256(1):146-56
pubmed: 22580939
Int J Pediatr. 2012;2012:645678
pubmed: 22611412

Auteurs

Aditi Mehta (A)

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi; Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Mandeep S Bajaj (MS)

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Neelam Pushker (N)

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Bhavna Chawla (B)

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Amar Pujari (A)

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Sartaj S Grewal (SS)

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi; Department of Ophthalmology, Grewal Eye Institute, Chandigarh, India.

Satinder Pal Singh Grewal (SPS)

Department of Ophthalmology, Grewal Eye Institute, Chandigarh, India.

Simar Rajan Singh (SR)

Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Alisha Kishore (A)

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Neha Singh Yadav (NS)

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH